CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas

Current Opinion in Immunology

Volumn 20, Issue 6, 2008, Pages 655-662

  Piccirillo, Ciriaco A ^a   d'Hennezel, Eva ^a   Sgouroudis, Evridiki ^a   Yurchenko, Ekaterina ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; LYMPHOCYTE FUNCTION; NONHUMAN; PATHOPHYSIOLOGY; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; ANTIGENS, CD4; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFLAMMATION; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 56749160115     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2008.09.006     Document Type: Review

References (63)

1. Sakaguchi S., Yamaguchi T., Nomura T., and Ono M. Regulatory T cells and immune tolerance. Cell 133 5 (2008) 775-787
2. + regulatory T cells. Trends Immunol 25 (2004) 374-380
3. Bach J.F. Regulatory T cells under scrutiny. Nat Rev Immunol 3 (2003) 189-198
4. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains [CD25]. Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
5. Asano M., Toda M., Sakaguchi N., and Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184 (1996) 387-396
6. + immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol 16 (2004) 81-88
7. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
8. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212 (2006) 8-27
9. Hsieh C.S., Zheng Y., Liang Y., Fontenot J.D., and Rudensky A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat Immunol 7 (2006) 401-410
10. + regulatory T cells. Nat Immunol 4 (2003) 330-336
11. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
12. + T regulatory cells. Nat Immunol 4 (2003) 337-342. These seminal studies identified Foxp3 as crucial transcription factor for the development of Treg cells.
13. Ochs H.D., Ziegler S.F., and Torgerson T.R. FOXP3 acts as a rheostat of the immune response. Immunol Rev 203 (2005) 156-164
14. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., Kelly T.E., Saulsbury F.T., Chance P.F., and Ochs H.D. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome [IPEX] is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
15. + Tregs. J Clin Invest 115 (2005) 3276-3284
16. + regulatory T cells. Int Immunol 16 (2004) 1643-1656
17. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341. This important study makes use of Foxp3-GFP knockin mice to characterize the factors dictating Foxp3 expression in thymocytes and periperal T cells.
18. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886. This paper was the first of several studies reporting that TGF-β1, in conjuction to TCR activation, can induce Foxp3 in naïve T cells upon.
19. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., Caccamo M., Oukka M., and Weiner H.L. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453 (2008) 65-71. This paper made the novel finding that selective AHR ligands can selectively induce Foxp3 in naïve T cells upon antigen activation.
20. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., and Cheroutre H. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317 5835 (2007) 256-260. This paper was the first to report that retinoic acid, particularly in the presence of TGF-β1, can selectively induce Foxp3 in naïve T cells upon antigen activation.
21. Yang X.O., Pappu B.P., Nurieva R., Akimzhanov A., Kang H.S., Chung Y., Ma L., Shah B., Panopoulos A.D., Schluns K.S., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28 (2008) 29-39
22. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., Blank R.B., Meylan F., Siegel R., Hennighausen L., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26 (2007) 371-381
23. + regulatory T cells. J Exp Med 201 (2005) 1061-1067
24. +] regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194 (2001) 629-644
25. + regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J Exp Med 205 (2008) 1975-1981
26. +) T cells. J Autoimmun 16 (2001) 115-123
27. + T cells during cure of colitis. J Immunol 177 9 (2006) 5852-5860
28. + and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol 9 (2007) 931-941
29. +) regulatory T cells. J Exp Med 201 (2005) 737-746
30. + regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol 35 (2005) 2886-2895
31. + Treg cells produce a novel cytokine, IL-35, which was responsible for a significant proportion of the in vitro and in vivo suppressive activity.
32. + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci U S A 105 (2008) 10113-10118
33. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 174 4 (2005) 1783-1786
34. Deaglio S., Dwyer K.M., Gao W., Friedman D., Usheva A., Erat A., Chen J.F., Enjyoji K., Linden J., Oukka M., et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204 (2007) 1257-1265
35. Fallarino F., Grohmann U., Hwang K.W., Orabona C., Vacca C., Bianchi R., Belladonna M.L., Fioretti M.C., Alegre M.L., and Puccetti P. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4 (2003) 1206-1212
36. + T cells. Nat Immunol 12 (2007) 1353-1362
37. Tang Q., Adams J.Y., Tooley A.J., Bi M., Fife B.T., Serra P., Santamaria P., Locksley R.M., Krummel M.F., and Bluestone J.A. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7 (2006) 83-92. These authors make use of 2-photon laser scanning microscopy to visualize Treg/DC interactions in the pancreatic lymph node of diabetes-prone NOD mice.
38. + Treg cells predispose to the onset of type 1 diabetes.
39. Levings M.K., Allan S., d'Hennezel E., and Piccirillo C.A. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. Adv Immunol 92 (2006) 119-155
40. + T reg cells impinge on autoimmune diabetes. J Exp Med 202 (2005) 1387-1397
41. Huehn J., and Hamann A. Homing to suppress: address codes for Treg migration. Trends Immunol 26 12 (2005) 632-636
42. + splenocytes that delays adoptive transfer of diabetes expresses l-selectin and high levels of CCR7. J Immunol 169 (2002) 2461-2465
43. Wei S., Kryczek I., and Zou W. Regulatory T-cell compartmentalization and trafficking. Blood 108 2 (2006) 426-431
44. + Treg cells to inflamed target tissues where they dampen anti-pathogen immunity and pathogen persistence.
45. + T-cell subset. Blood 105 (2005) 2877-2886
46. Annacker O., Coombes J.L., Malmstrom V., Uhlig H.H., Bourne T., Johansson-Lindbom B., Agace W.W., Parker C.M., and Powrie F. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med 202 8 (2005) 1051-1061
47. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., Nochy D., Debre P., Piette J.C., and Gorochov G. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 175 (2005) 8392-8400
48. + regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 117 (2006) 280-286
49. + T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 59 (2004) 198-202
50. Ounissi-Benkalha H., and Polychronakos C. The molecular genetics of type 1 diabetes: new genes and emerging mechanisms. Trends Mol Med 14 (2008) 268-275
51. Bluestone J.A., Thomson A.W., Shevach E.M., and Weiner H.L. What does the future hold for cell-based tolerogenic therapy?. Nat Rev Immunol 7 (2007) 650-654
52. + T reg cells. J Exp Med 203 (2006) 1701-1711
53. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12 (2000) 431-440
54. + Treg cells.
55. +] T reg homeostasis through dendritic cell-produced IL-2. Eur J Immunol 35 (2005) 557-567
56. Costantino C.M., Baecher-Allan C.M., and Hafler D.A. Human regulatory T cells and autoimmunity. Eur J Immunol 38 4 (2008) 921-924
57. -/- Foxp3-GFP knockin reporter mice were used to show that IL-2 is crucial for maintaining the expression of genes involved in controlling cell growth and metabolism, in turn sustaining the homeostasis and competitive fitness of nTreg cells in vivo.
58. Tang Q., Adams J.Y., Penaranda C., Melli K., Piaggio E., Sgouroudis E., Piccirillo C.A., Salomon B.L., and Bluestone J.A. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 5 (2008) 687-697. This study demonstrates that intra-islet Treg cell dysfunction, secondary to defective IL-2 production, is a cause of the time-dependent breakdown of self-tolerance and the development of diabetes in nonobese diabetic mice.
59. Leiter E.H. Nonobese diabetic mice and the genetics of diabetes susceptibility. Curr Diab Rep 5 (2005) 141-148
60. Yamanouchi J., Rainbow D., Serra P., Howlett S., Hunter K., Garner V.E., Gonzalez-Munoz A., Clark J., Veijola R., Cubbon R., et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 3 (2007) 329-337. This seminal study identifies the il2 gene as the primary gene candidate for resistance to diabetes in protective Idd3 alleles in NOD mice.
61. + Treg cells in inflamed organs.
62. Vella A., Cooper J.D., Lowe C.E., Walker N., Nutland S., Widmer B., Jones R., Ring S.M., McArdle W., Pembrey M.E., et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76 (2005) 773-779
63. Qu H.Q., Montpetit A., Ge B., Hudson T.J., and Polychronakos C. Toward further mapping of the association between the IL2RA locus and type 1 diabetes. Diabetes 56 (2007) 1174-1176